Specialised Trials

Specialised Trials, founded in 2018, is an Australian entity focused on providing dedicated pathology management solutions for pharmaceutical and biotechnology clients engaged in Phase I-IV clinical trials. The company leverages its expertise to streamline complex trial processes, offering a comprehensive suite of services designed to support research and development initiatives. Despite the provided industry classification of 'Insurance', the company's core operations revolve around specialized pathology services crucial for clinical research.

The organization offers extensive test offerings, electronic request forms, participant specimen collections, and robust logistics solutions. Operating from a NATA accredited facility, Specialised Trials ensures high-quality support and reliable data management throughout the trial lifecycle. Backed by a leading pathology provider, the company is equipped to handle demanding trial requirements. Meet Specialised Trials's team to understand the expertise driving their client-focused approach. Their commitment is to facilitate a seamless transition from initial inquiry to final delivery, enhancing the overall efficiency of clinical trial execution.

With a revenue of $3.7M and an employee range of 1,000-5,000, Specialised Trials operates within a competitive landscape that includes CROs like Novotech and Southern Star Research, as well as larger life science companies. The company's stated location count is zero, suggesting a centralized operational focus or potential data limitation. Specialised Trials aims to enhance the clinical trial process through its specialized pathology management, ensuring quality and efficiency for its partners in the pharmaceutical and biotechnology sectors.